Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.67 |
| ▸ | MAPT | P10636 | 5/20 | 0.67 |
| ▸ | CYP1A1 | P04798 | 5/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.67 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.67 |
| ▸ | MEN1 | O00255 | 4/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.67 |
| ▸ | FTO | Q9C0B1 | 3/20 | 0.67 |
| ▸ | PKM | P14618 | 2/20 | 0.67 |
| ▸ | AR | P10275 | 1/20 | 0.67 |
| ▸ | GABRP | O00591 | 4/20 | 0.63 |
| ▸ | GABRD | O14764 | 4/20 | 0.63 |
| ▸ | GABRA1 | P14867 | 4/20 | 0.63 |
| ▸ | GABRB1 | P18505 | 4/20 | 0.63 |
| ▸ | GABRG2 | P18507 | 4/20 | 0.63 |
| ▸ | GABRB3 | P28472 | 4/20 | 0.63 |
| ▸ | GABRA5 | P31644 | 4/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8934562 | 0.88 | MEN1 (0.67) | ALDH1A1MAPTCYP1A1CYP1A2CYP1B1 | |
| SCHEMBL23299597 | 0.87 | CDK5 (0.72) | ALDH1A1MAPTCYP1A1CYP1A2CYP1B1 | |
| SCHEMBL30738943 | 0.84 | ACHE (0.73) | ALDH1A1MAPTCYP1A1CYP1A2CYP1B1 | |
| Norwogonin SCHEMBL760431 | 0.84 | GABRP (0.68) | ALDH1A1MAPTCYP1A1CYP1A2CYP1B1 | |
| Norwogonin SCHEMBL30485998 | 0.84 | GABRP (0.68) | ALDH1A1MAPTCYP1A1CYP1A2CYP1B1 | |
| SCHEMBL12835534 | 0.83 | ABCB1 (0.55) | ALDH1A1MAPTCYP1A1CYP1A2CYP1B1 | |
| SCHEMBL29149073 | 0.81 | GABRP (0.70) | ALDH1A1MAPTCYP1A1CYP1A2CYP1B1 | |
| SCHEMBL28066043 | 0.81 | GABRP (0.65) | ALDH1A1MAPTCYP1A1CYP1A2CYP1B1 | |
| 5-Hydroxyflavone SCHEMBL2390993 | 0.80 | AR (1.00) | ALDH1A1MAPTCYP1A1CYP1A2CYP1B1 | |
| 5-Hydroxyflavone SCHEMBL30630415 | 0.80 | AR (1.00) | ALDH1A1MAPTCYP1A1CYP1A2CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4698662-A2 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | AskBio Inc. (US) | 2026-02-25 | — | — | EP | claimed |
| US-20250367305-A1 | ALBUMIN NANOCOMPOSITE COMPRISING PHYTOCHEMICAL AND COMPOSITION FOR IMPROVING MUSCLE DISEASE CONTAINING SAME | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2025-12-04 | — | — | US | claimed |
| CN-120005740-A | Recombinant microorganism for high-level synthesis of polyphenol compounds and application thereof | 中国科学院天津工业生物技术研究所 | 2025-05-16 | — | — | CN | claimed |
| WO-2024220449-A9 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | AskBio Inc. (US) | 2025-04-03 | — | — | WO | claimed |
| US-20250011393-A1 | FLAVONOID-COLLAGEN CROSSLINKED ANTIOXIDANT HYDROGEL | NORTH CAROLINA STATE UNIVERSITY | 2025-01-09 | — | — | US | claimed |
| WO-2024220449-A2 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | ASKLEPIOS BIOPHARMACEUTICAL, INC. (US) | 2024-10-24 | — | — | WO | claimed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| WO-2024177490-A1 | ALBUMIN NANOCOMPOSITE COMPRISING PHYTOCHEMICAL AND COMPOSITION FOR IMPROVING MUSCLE DISEASE CONTAINING SAME | 서울대학교산학협력단 | 2024-08-29 | — | — | WO | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2021158575-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| US-8530426-B2 | Topical use of a UGT inducer-containing composition comprising a dermatologically acceptable carrier to protect and/or enhance the state of the skin/hair and prevent and/or treat imperfections of the skin; flavanoids such as chrysin stimulates isoforms; protective coatings aging/ wrinkling resistance | SEDERMA SAS (FR) | 2013-09-10 | — | — | US | claimed |
| US-5650433-A | REDUCING ARTICULAR CARTILAGE DESTRUCTION IN A PATIENT BY ADMINISTERING A FLAVONOID COMPOUND | KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) | 1997-07-22 | — | — | US | claimed |
| EP-0633022-B1 | Chondroprotective flavones | KUREHA CHEMICAL IND CO LTD (JP) | 1997-02-19 | — | — | EP | claimed |
| WO-1996031206-A2 | FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS | WARNER-LAMBERT COMPANY (US) | 1996-10-10 | — | — | WO | claimed |
| EP-0496349-B1 | Coating solution for preventing adhesion of polymer scale and method for its use | SHINETSU CHEMICAL CO (JP) | 1996-04-10 | — | — | EP | claimed |
| CN-1100633-A | Chondroprotective agents | KUREHA CHEMICAL IND CO LTD (JP) | 1995-03-29 | — | — | CN | claimed |
| EP-0633022-A2 | Chondroprotective flavones | KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) | 1995-01-11 | — | — | EP | claimed |
| EP-0496349-A1 | Coating solution for preventing adhesion of polymer scale and method for its use | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1992-07-29 | — | — | EP | claimed |
| US-4617293-A | Flavonoid phosphate salts of aminoglycoside antibiotics | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1986-10-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | ALDH1A1 2722/4885MAPT 3926/4885CYP1A1 3564/4885 |
| US-20250367305-A1 | ALBUMIN NANOCOMPOSITE COMPRISING PHYTOCHEMICAL AND COMPOSITION FOR IMPROVING MUSCLE DISEASE CONTAINING SAME | ALB, TNNC1, MYOF | ALDH1A1 2635/4885MAPT 629/4885CYP1A1 3366/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.